| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 65.5694 | 67 |
| GSM780708 | Untreated after 4 days (C2_1) | 61.7305 | 66 |
| GSM780709 | Untreated after 4 days (C3_1) | 69.4799 | 69 |
| GSM780719 | Untreated after 4 days (C1_2) | 63.5912 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 64.8532 | 67 |
| GSM780721 | Untreated after 4 days (C3_2) | 65.0547 | 67 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 72.5636 | 70 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 63.5507 | 66 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 83.3536 | 72 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.057 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 71.3543 | 69 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 69.9416 | 69 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.2361 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 62.0639 | 66 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 80.4037 | 72 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 60.7917 | 65 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 58.8407 | 64 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 63.1608 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 59.3071 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 70.2348 | 69 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 72.3741 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 76.774 | 71 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 60.9424 | 65 |